Decoy Therapeutics Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
Mailing Address
2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
Phone
346-772-0346
Fiscal Year End
1231
EIN
465087339
Financial Overview
FY2025
$5.89M
Stockholders' Equity
$-69.54
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 5, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 9, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Advancing lead clinical candidates SP2577 and SP3164 for oncology treatments.
- Maintained Nasdaq compliance through strategic reverse stock splits.
Material Events
8-K
Strategy Change
February 25, 2026
High Impact
- Focuses on developing novel therapies for unmet medical needs, a high-growth sector.
- Approved a new Equity Incentive Plan to attract, retain, and motivate key talent, aligning interests with shareholder value.
8-K
Financial Distress
January 2, 2026
High Impact
- Salarius Pharmaceuticals received a notice from Nasdaq regarding delisting due to its common stock's closing bid price falling below $1.00 for 30 consecutive business days.
- The company is not eligible for the usual grace period due to a recent reverse stock split and being under a 'Mandatory Panel Monitor' by Nasdaq.
Insider Trading
BUY
2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.